Navigation Links
NIH/NHLBI-Funded PACT Program Announces Webcast Scheduled for Tuesday, May 4, 2010, 2:00-4:00 pm ET
Date:3/26/2010

Production Assistance for Cellular Therapies (PACT) is pleased to announce the scheduling of a webcast to be held on Tuesday May 4, 2010, 2:00 pm ET. This is a free, interactive webcast to discuss the PACT program and to answer participants’ questions about the program’s goals, the application process and criteria, and the details surrounding PACT product manufacturing and translational services. Online Registration Opens April 5, 2010, Register online at www.pactgroup.net.

Rockville, MD (PRWEB) March 26, 2010 -- Production Assistance for Cellular Therapies (PACT) is pleased to announce the scheduling of a webcast to be held on Tuesday May 4, 2010, 2:00 pm ET. This is a free, interactive webcast to discuss the PACT program and to answer participants’ questions about the program’s goals, the application process and criteria, and the details surrounding PACT product manufacturing and translational services.

Webcast Description:
Representatives from the five PACT Cell Processing Facilities will present on novel clinical and translational development projects:

 
  • Baylor College of Medicine, Center for Cell and Gene Therapy
  • Center for Human Cell Therapy Boston
  • City of Hope, Center for Applied Technology Development
  • University of Minnesota, Molecular and Cellular Therapeutics Facility
  • University of Wisconsin - Madison, Waisman Clinical BioManufacturing Facility
The process for requesting PACT services will be discussed followed by a Question and Answer Session

Online Registration Opens April 5, 2010:
Register online at www.pactgroup.net. Registrants will receive an email with instructions for accessing the audio and Internet portions of the webcast one week prior to the webcast.

Intended Audience:
Clinical Investigators, Scientists, Researchers, and Technologists specializing in cell therapy

About PACT:
PACT is an NHLBI-funded initiative that is committed to the advancement of effective cell therapies. PACT supports the development of novel cell therapy products by providing production assistance to the cell therapy community, as well as educational training via web seminars and at meetings. Production assistance is provided through the funded contract manufacturing of therapeutic cell products at five PACT cell processing facilities. These facilities offer scale-up capability and expertise in the translational development needed to produce cell therapy products under cGMP and cGTP regulations. PACT’s educational training focuses on translational development, scale-up and manufacture of cell therapy products, quality assurance and regulatory issues.

Applications:
PACT is currently accepting and evaluating applications for product manufacturing and translational services. Applications can be submitted online through the PACT website at www.pactgroup.net.

More information about PACT is available at www.pactgroup.net.

Contact Information
PACT, Rockville, MD
Jamie Winestone or Debbie Wood
phone: 301-251-1161
email: pactinfo(at)pactgroup(dot)net

This project has been funded in whole or in part with Federal funds from the NHLBI, NIH
under Contract No. HHSN268201000006C

###

Read the full story at http://www.prweb.com/releases/2010/03/prweb3792194.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. NIH/NHLBI-funded PACT Group Announces the Renewal of Production Assistance for Cellular Therapies (PACT)
2. Drug Information Association (DIA) Announces New Clinical Safety and Pharmacovigilance Certificate Program
3. Greys Anatomy Star Chandra Wilson Delivers the Downy Touch of Comfort Program to Charlotte, North Carolina
4. Keenan Selects Nurtur and Healthyroads for Integrated Disease Management and Personal Wellness Programs
5. Texas Health Dallas Launches Screening Program for Female Heart Disease
6. Verizon Wireless Supports Text4baby Program
7. Good Vibrations Announces Enhanced Education Program
8. Aleres Dr. Michael Taitel Presents Compelling Evidence at IBI/NBCH Health & Productivity Forum that Wellness Programs Positively Impact Health & Productivity
9. Children's Health Insurance Program Helping Families Get Through Tough Times
10. American Wholesalers Underwriting Ltd Adds Environmental Protection to Wholesalers Insurance Program, WIP(R)
11. Unique Clean Energy Program Helps Hospitals Buy Clean Energy, Reduce Costs and Counteract Climate Change
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NIH/NHLBI-Funded PACT Program Announces Webcast Scheduled for Tuesday, May 4, 2010, 2:00-4:00 pm ET 
(Date:2/6/2016)... ... 2016 , ... Research has shown that building shame resilience ... and level of relapse. , At the 2016 iaedp Symposium, the ... the critical tasks of the recovery phase and beyond including relapse prevention and ...
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the ... a variety of colors, assortments and packaging. This staple for Valentine’s Day is a ... location. , For Valentine’s Day, not only are long-stem roses available, but also ...
(Date:2/5/2016)... City, UT (PRWEB) , ... February 05, 2016 , ... ... Whole-Food Nutrition , announced that the much-anticipated feature with author Jahnavi Foster, specialist in ... Humans Amateur TV Network. , Each week, on his weekly Whole-Food Warrior TV show, ...
(Date:2/5/2016)... ... February 05, 2016 , ... The event is being held ... Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research ... Schneiderman’s Furniture, lives with Parkinson’s disease and is the architect of this informative event ...
(Date:2/5/2016)... Santa Rosa, CA (PRWEB) , ... February 05, ... ... are pleased to announce the addition of micro-needling services in their Napa Valley ... appearance. The founders of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... 2016 Wegener Polyangiitis - Pipeline Review, ... ,Wegener Polyangiitis - Pipeline Review, H2 2015, provides ... This report provides comprehensive information on the ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
(Date:2/4/2016)... -- Omnicell, Inc. (NASDAQ: OMCL ), a leading provider of ... announced results for its fiscal year and fourth quarter ... --> GAAP results: Revenue for the fourth quarter ... 4.1% from the third quarter of 2015, and up ... 2014. Revenue for the year ended December 31, 2015 was ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology: